Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus

BACKGROUND: Co-administration of anti-tuberculosis and antiretroviral therapy is often inevitable in high-burden countries where tuberculosis is the most common opportunistic infection associated with HIV/AIDS. Concurrent use of rifampicin and several antiretroviral drugs is complicated by pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Semvua, Hadija H, Kibiki, Gibson S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236078/
https://www.ncbi.nlm.nih.gov/pubmed/22114934
http://dx.doi.org/10.1186/1756-0500-4-511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236078/
https://www.ncbi.nlm.nih.gov/pubmed/22114934
http://dx.doi.org/10.1186/1756-0500-4-511

Ejemplares similares